• 1
    Lambert S, O'Grady KA, Gabriel S, Carter R, Nolan T. The cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use. Commun Dis Intell 2004; 28:510516.
  • 2
    Iskander M, Booy R, Lambert S. The burden of influenza in children. Curr Opin Infect Dis 2007; 20:259263.
  • 3
    Lambert SB, Allen KM, Carter RC, Nolan TM. The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children. Respir Res 2008; 9:11.
  • 4
    Hoen AG, Buckeridge DL, Charland KML, Mandl KD, Quach C, Brownstein JS. Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada. CMAJ 2011; 183:E1025E1032.
  • 5
    Hoberman A, Greenberg DP, Paradise JL. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003; 290:16081616.
  • 6
    Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 2008; 153:764770.
  • 7
    Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970; 122:1625.
  • 8
    Hurwitz ES, Haber M, Chang A. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284:16771682.
  • 9
    Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344:889896.
  • 10
    Piedra PA, Gaglani MJ, Kozinetz CA. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23:15401548.
  • 11
    Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134:7178.
  • 12
    Davis MM, King JC Jr, Moag L, Cummings G, Magder LS. Countywide school-based influenza immunization: direct and indirect impact on student absenteeism. Pediatrics 2008; 122:e260e265.
  • 13
    Kwong JC, Stukel TA, Lim J. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008; 5:e211.
  • 14
    Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:162.
  • 15
    Kelly H, Jacoby P, Dixon GA. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case–control study. Pediatr Infect Dis J 2011; 30:107111.
  • 16
    Letter to General Practitioners – Update on Pandemic (H1N1) 2009 Influenza Vaccination. 2010. Available at (Accessed 12 December 2012)
  • 17
    Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008; 8:CD004879.
  • 18
    Nolan T, Richmond PC, McVernon J. Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children. Influenza Other Respi Viruses 2009; 3:315325.
  • 19
    A study to determine the immunogenicity and safety profile of CSL Limited's influenza virus vaccine compared to a US licensed comparator influenza virus vaccine in a pediatric population. Available at (Accessed 12 December 2012).
  • 20
    Whiley DM, Bialasiewicz S, Bletchly C. Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol 2009; 45:203204.
  • 21
    Appuhamy RD, Beard FH, Phung HN, Selvey CE, Birrell FA, Culleton TH. The changing phases of pandemic (H1N1) 2009 in Queensland: an overview of public health actions and epidemiology. Med J Aust 2010; 192:9497.
  • 22
    Armstong PK, Dowse GK, Effler PV. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open 2011; e000016.
  • 23
    Clinical advice for immunisation providers on resumption of the use of 2010 trivalent seasonal vaccines in children less than 5 years of age, July 2010. 2010. Available at (Accessed 12 December 2012).
  • 24
    Nolan T, McVernon J, Skeljo M. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010; 303:3746.
  • 25
    A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA. Available at (Accessed 12 December 2012).
  • 26
    Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children. Attachment E: TGA influenza seasonal trivalent influenza vaccine laboratory investigation program. Available at (Accessed 12 December 2012).
  • 27
    Kelly HA, Skowronski DM, De Serres G, Effler PV. Adverse events associated with 2010 CSL and other inactivated influenza vaccines. Med J Aust 2011; 195:318320.
  • 28
    Blyth CC, Currie AJ, Wiertsema SP. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine 2011; 29:51075113.
  • 29
    Maraskovsky E, Rockman S, Dyson A. Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine. Vaccine 2012; 30:74007406.